Plunkett Research Online: Bavarian Nordic

BAVARIAN NORDIC (BVNKF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Bavarian Nordic is committed to building a pipeline of immunotherapy candidates for major cancers with large unmet medical needs. The Company leverages its viral vaccine platforms to create novel, non-patient specific immunotherapy candidates to efficiently target and kill cancer cells while sparing.....



Bavarian Nordic
Ticker: BVNKF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 45 33268383
Fax: 45 33268380
Address: Hejreskovvej 10A
Kvistgaard, 3490 Denmark

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription

Bavarian Nordic is committed to building a pipeline of immunotherapy candidates for major cancers with large unmet medical needs. The Company leverages its viral vaccine platforms to create novel, non-patient specific immunotherapy candidates to efficiently target and kill cancer cells while sparing.....See More See More

Auditor: Deloitte Statsautoriseret Revisionspartnerselskab
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: